LOXL2, Human (HEK293, His)
LOXL2 protein mediates post-translational oxidative deamination of lysine residues, leading to the formation of allysine. It specifically deaminates H3K4me3, inhibits TFIID-dependent transcription, represses E-cadherin, activates the IRE1-XBP1 pathway, and promotes cross-linking of extracellular matrix proteins. LOXL2 is involved in EMT, tumor progression, angiogenesis regulation, and chondrocyte differentiation. LOXL2 Protein, Human (HEK293, His) is the recombinant human-derived LOXL2 protein, expressed by HEK293 , with C-His labeled tag.
Product Specifications
Product Name Alternative
LOXL2 Protein, Human (HEK293, His), Human, HEK293
UNSPSC
12352202
Type
Recombinant Proteins
Assay Protocol
https://www.medchemexpress.com/cytokines/loxl2-protein-human-hek293-his.html
Purity
98.0
Smiles
Molecular Formula
4017 (Gene_ID) Q9Y4K0 (M26-Q774) (Accession)
Molecular Weight
Approximately 110 kDa
Shipping Conditions
Room temperature in continental US; may vary elsewhere.
Storage Conditions
Stored at -20°C for 2 years
Scientific Category
Recombinant Proteins
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 17 (E3), CF740 conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF488A conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF594 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
